New Immunotherapy Findings from University of Pittsburgh Reported (Intraperitoneal Injection of Class a Tlr9 Agonist Enhances Anti-pd-1 Immunotherapy In Colorectal Peritoneal Metastases)

  • Timothy Billiar

Press/Media

Period28 Nov 2022

Media coverage

1

Media coverage

  • TitleNew Immunotherapy Findings from University of Pittsburgh Reported (Intraperitoneal Injection of Class a Tlr9 Agonist Enhances Anti-pd-1 Immunotherapy In Colorectal Peritoneal Metastases)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date28/11/22
    PersonsTimothy Billiar
View all 1
View less

Related content